Stone X Group Inc. Citius Pharmaceuticals, Inc. Transaction History
Stone X Group Inc.
- $2.29 Trillion
- Q3 2025
Shares
1 transactions
Others Institutions Holding CTXR
# of Institutions
4Shares Held
1.96MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY1.81MShares$1.73 Million0.0% of portfolio
-
Key Bridge Compliance, LLC Covington, KY154KShares$147,9640.03% of portfolio
-
American Portfolios Advisors Holbrook, NY4KShares$3,8400.0% of portfolio
-
Clear Perspectives Financial Planning, LLC Cincinnati, OH400Shares$3840.0% of portfolio
About Citius Pharmaceuticals, Inc.
- Ticker CTXR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 146,130,000
- Market Cap $140M
- Description
- Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of critical care products focusing on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy. The company is developing five proprietary products comprising Mino-Lok, an antibiotic l...